Glottic carcinoma with a fixed true vocal cord: outcomes after neoadjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy.
Twenty patients with glottic squamous cell carcinoma and a fixed true vocal cord underwent neoadjuvant chemotherapy followed by supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Phonation, respiration, and deglutition were preserved. Local control was better than has been previously reported for either extended vertical partial laryngectomy or radiation therapy. All patients were monitored for at least 3 years or until death. The Kaplan-Meier 3-year survival, local recurrence, nodal recurrence, distant metastasis, and second primary rates were 75%, 10.8%, 5%, 10.8%, and 10.8%, respectively. Overall local control was achieved in all cases, and laryngeal preservation in 90%. Our experience suggested that neoadjuvant chemotherapy with supracricoid partial laryngectomy with cricohyoidoepiglottopexy deserves further consideration in the treatment of glottic tumors with a fixed true vocal cord.
Laccourreye
O
O
Department of Otorhinolaryngology-Head and Neck Surgery, Hôpital Laënnec, Paris, France.
Salzer
S J
SJ
Brasnu
D
D
Shen
W
W
Laccourreye
H
H
Weinstein
G S
GS
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003413:Cricoid Cartilage / Q000601:surgery; D004825:Epiglottis / Q000601:surgery; D005931:Glottis / Q000187:drug effects / Q000473:pathology* / Q000601:surgery*; D006801:Humans; D006928:Hyoid Bone / Q000601:surgery; D007825:Laryngectomy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D014827:Vocal Cords / Q000473:pathology* / Q000601:surgery*